X-108174500-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033641.4(COL4A6):​c.3078C>T​(p.Gly1026=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.251 in 1,208,104 control chromosomes in the GnomAD database, including 30,479 homozygotes. There are 99,687 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 3298 hom., 8661 hem., cov: 22)
Exomes 𝑓: 0.25 ( 27181 hom. 91026 hem. )

Consequence

COL4A6
NM_033641.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.250
Variant links:
Genes affected
COL4A6 (HGNC:2208): (collagen type IV alpha 6 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant X-108174500-G-A is Benign according to our data. Variant chrX-108174500-G-A is described in ClinVar as [Benign]. Clinvar id is 258271.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.591 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL4A6NM_033641.4 linkuse as main transcriptc.3078C>T p.Gly1026= synonymous_variant 31/45 ENST00000334504.12

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL4A6ENST00000334504.12 linkuse as main transcriptc.3078C>T p.Gly1026= synonymous_variant 31/455 NM_033641.4 P4Q14031-2

Frequencies

GnomAD3 genomes
AF:
0.268
AC:
29575
AN:
110542
Hom.:
3293
Cov.:
22
AF XY:
0.263
AC XY:
8631
AN XY:
32848
show subpopulations
Gnomad AFR
AF:
0.277
Gnomad AMI
AF:
0.220
Gnomad AMR
AF:
0.476
Gnomad ASJ
AF:
0.186
Gnomad EAS
AF:
0.613
Gnomad SAS
AF:
0.372
Gnomad FIN
AF:
0.135
Gnomad MID
AF:
0.214
Gnomad NFE
AF:
0.213
Gnomad OTH
AF:
0.267
GnomAD3 exomes
AF:
0.319
AC:
58149
AN:
182244
Hom.:
8246
AF XY:
0.303
AC XY:
20245
AN XY:
66786
show subpopulations
Gnomad AFR exome
AF:
0.282
Gnomad AMR exome
AF:
0.623
Gnomad ASJ exome
AF:
0.190
Gnomad EAS exome
AF:
0.606
Gnomad SAS exome
AF:
0.382
Gnomad FIN exome
AF:
0.147
Gnomad NFE exome
AF:
0.208
Gnomad OTH exome
AF:
0.278
GnomAD4 exome
AF:
0.249
AC:
273774
AN:
1097504
Hom.:
27181
Cov.:
32
AF XY:
0.251
AC XY:
91026
AN XY:
363012
show subpopulations
Gnomad4 AFR exome
AF:
0.289
Gnomad4 AMR exome
AF:
0.603
Gnomad4 ASJ exome
AF:
0.188
Gnomad4 EAS exome
AF:
0.669
Gnomad4 SAS exome
AF:
0.379
Gnomad4 FIN exome
AF:
0.154
Gnomad4 NFE exome
AF:
0.216
Gnomad4 OTH exome
AF:
0.262
GnomAD4 genome
AF:
0.268
AC:
29604
AN:
110600
Hom.:
3298
Cov.:
22
AF XY:
0.263
AC XY:
8661
AN XY:
32914
show subpopulations
Gnomad4 AFR
AF:
0.277
Gnomad4 AMR
AF:
0.477
Gnomad4 ASJ
AF:
0.186
Gnomad4 EAS
AF:
0.613
Gnomad4 SAS
AF:
0.375
Gnomad4 FIN
AF:
0.135
Gnomad4 NFE
AF:
0.213
Gnomad4 OTH
AF:
0.263
Alfa
AF:
0.260
Hom.:
5006
Bravo
AF:
0.299
EpiCase
AF:
0.217
EpiControl
AF:
0.212

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMay 09, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hearing loss, X-linked 6 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.3
DANN
Benign
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5973851; hg19: chrX-107417730; COSMIC: COSV57873330; API